Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

aBIOTECH, published by SPRINGERNATURE, is a premier academic journal dedicated to advancing the fields of biotechnology, agronomy, and molecular biology. With an impressive ISSN of 2096-6326 and E-ISSN 2662-1738, this journal has established itself as a vital resource for researchers and professionals aiming to publish high-quality, impactful studies. Based in Singapore, aBIOTECH has achieved remarkable recognition, boasting a Q1 ranking in multiple categories including Agronomy and Crop Science, Biochemistry, and Genetics in the 2023 Scopus rankings. Its solid position in the 90th percentile for Biochemistry and Genetics reinforces its significance within the global scientific community. The journal covers a broad spectrum of topics relevant to both basic and applied research, facilitating a shared dialogue amongst scientists and encouraging collaborative progress in innovative biotechnological applications. The open-access nature of the journal ensures that cutting-edge research is freely available, fostering a global exchange of ideas that is critical to the advancement of science today.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

Industrial Biotechnology, published by Mary Ann Liebert, Inc., is a premier journal dedicated to the rapidly evolving field of biotechnology with a particular focus on its applications in industrial settings. Since its inception in 2006, this influential journal has been a vital resource for researchers and professionals keen on exploring innovative bioprocesses and the sustainable use of biological systems in industry. With an ISSN of 1550-9087 and an E-ISSN of 1931-8421, Industrial Biotechnology maintains a Q3 ranking in the biotechnology category, ranking 216 out of 311 in Scopus, signifying its growing impact in the field despite a current percentile rank of 30. This journal collects and disseminates significant findings that bridge the gap between science and technology, emphasizing ecological sustainability and economic viability in industrial practices. While offering traditional subscription options, it connects readers with cutting-edge advancements that shape modern biotechnology. As you delve into the pages of Industrial Biotechnology, expect to uncover groundbreaking research and pivotal insights that foster the advancement of this vital discipline.

Biocatalysis and Agricultural Biotechnology, published by Elsevier, is a distinguished journal in the fields of agronomy, biotechnology, and applied microbiology. With an E-ISSN of 1878-8181, this journal has an impressive impact factor and consistently ranks in the top quadrants of Scopus, notably Q1 in Agronomy and Crop Science and Q2 in several related categories. Since its inception in 2012, it aims to bridge the gap between biocatalysis applications and agricultural practices, fostering innovative research that advances sustainable agriculture and biotechnological applications. The journal is highly regarded, with a Scopus rank of #47 out of 406 in Agronomy and Crop Science, exemplifying its significance in the academic community. As an essential resource for researchers, professionals, and students, it provides a platform for sharing cutting-edge findings that address crucial global challenges in food security, environmental sustainability, and biotechnological advancements. Located in Amsterdam, Netherlands, the journal continues to contribute to the growth and interdisciplinary dialogue in agricultural and biological sciences.

JOURNAL OF KING SAUD UNIVERSITY SCIENCE, published by Elsevier, stands as a key resource in the field of multidisciplinary research, featuring a notable Impact Factor evident from its 2023 Q1 categorization and impressive Scopus rank of #16 out of 171, placing it in the top 10% of its category. Since its transition to Open Access in 2009, this journal has fostered greater accessibility to pioneering research outcomes and innovative methodologies, enhancing knowledge dissemination globally. With an established history dating back to 1994 and an ongoing commitment to advancing scientific exploration until 2024, it serves as a vital platform for researchers, professionals, and students alike. This journal aims to publish high-quality articles that bridge various scientific disciplines, thereby encouraging collaboration and innovation. With its base in the Netherlands, JOURNAL OF KING SAUD UNIVERSITY SCIENCE not only reflects the academic rigor of its publisher but also engages a diverse international readership, making it an indispensable tool for the modern scientist.

Current Opinion in Biotechnology, published by Elsevier Science Ltd, is a premier academic journal dedicated to providing critical insights and evaluations on emerging trends and developments in the ever-evolving fields of biotechnology and bioengineering. With an impressive impact factor and ranking in the Q1 quartile across bioengineering, biomedical engineering, and biotechnology, this journal serves as an indispensable resource for researchers, professionals, and students alike. Spanning from 1990 to 2024, the journal facilitates scholarly discourse by featuring concise reviews authored by leading experts, covering cutting-edge topics and innovative technologies. With a strong presence in renowned databases such as Scopus, where it ranks within the top percentiles in multiple categories, Current Opinion in Biotechnology not only contributes to the academic community but also impacts industry practices, making it a highly relevant platform for those looking to stay at the forefront of biotechnology innovation.